市场调查报告书
商品编码
1433400
全球妇科器材市场 2023-2030Global Gynecological Devices Market 2023-2030 |
预计在预测期(2023-2030年),全球妇科设备市场将以7.9%的CAGR成长。该市场的成长归因于全球对改进诊断的需求不断增长。具有改进诊断能力的设备需求量很大,因为它更注重早期检测和预防性医疗保健。例如,2023年10月,奥林巴斯公司推出了下一代EVIS X1内视镜系统。 TXI技术提高了病灶和息肉的可见度,RDI检测深层血管和出血色素沉着,BAI-MAC提高黑暗区域的亮度水平,NBI在EVIS X1内视镜设备上观察黏膜和血管模式。它还具有用于加快处理速度的触控面板和用于个人化影像配置的 MyCV 模式。
全球妇科设备市场分为内视镜设备、子宫内膜消融设备和避孕设备。根据内视镜设备,市场细分为子宫腔镜、电切镜、阴道镜、腹腔镜和内视镜成像系统。依子宫内膜消融设备,市场分为球囊消融设备、水热消融设备、射频消融设备等。此外,根据避孕装置,市场细分为临时节育、永久性节育、诊断影像系统、液体管理系统等。腹腔镜企业子类别预计将占据内视镜设备领域的很大一部分市场。这种增长可归因于腹腔镜手术的众多好处,包括失血量少、住院时间短以及术中和术后问题较少。
在内视镜设备中,子宫腔镜细分市场预计将在全球妇科设备市场中占据相当大的份额。细分市场的成长归因于对提高技能和护理品质的需求不断增长。改良的培训方法可以培养出更熟练的从业人员,最终提高子宫腔镜患者的治疗品质。例如,2021年2月,VirtaMed推出子宫腔镜和妇科腹腔镜混合实境平台。子宫腔镜训练涵盖16 个MyoSure 组织切除实例,以及50 多个诊断、息肉切除术、子宫肌瘤切除术、组织消融和高级电外科切除术实例,所有这些都具有基于能力的客观反馈和併发症管理。妇科腹腔镜模拟器模拟手术状况。
全球妇科设备市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,预计亚太地区将在全球市场中占据显着份额,因为人们对节育和避孕的认识不断增强,政府寻求减少人口增长,从而可以提振该地区的产品需求。根据世界卫生组织的数据,2023 年9 月,过去二十年来,妇女对计划生育的需求显着增加,从2000 年的9 亿增加到2021 年的约11 亿。此外,现代避孕技术的采用也促进了妇女的计划生育需求。增加,从2000 年的6.63 亿增加到2020 年的8.51 亿。根据预测,到2030 年,预计将有7000 万女性超过这一结果,避孕普及率呈现良好趋势,从47.7% 增加到49.0% 2000 年至 2020 年间。
事实
Global Gynecological Devices Market Size, Share & Trends Analysis Report by Endoscopy Devices (Hysteroscope, Resectoscope, Colposcope, Laparoscope, and Endoscopic Imaging Systems), by Endometrial Ablation Devices (Balloon Ablation Devices, Hydrothermal Ablation Devices, Radiofrequency Ablation Devices, and Others) and by Contraceptive Devices (Temporary Birth Control, Permanent Birth Control, Diagnostic Imaging Systems, Fluid Management Systems, and Others), Forecast Period (2023-2030)
The global gynecological devices market is anticipated to grow at a CAGR of 7.9% during the forecast period (2023-2030). The market's growth is attributed to the growing demand for improved diagnostics across the globe. Devices that have improved diagnostic capabilities are in high demand, as it contains an increased focus on early detection and preventive healthcare. For Instance, in October 2023, Olympus Corporation, launched next-generation EVIS X1 endoscopy system. The TXI technology improves visibility of lesions and polyps, RDI detects deep blood vessels and bleeding pigmentation, BAI-MAC improves brightness levels in dark areas, and NBI observes mucosal and vascular patterns on the EVIS X1 endoscopy equipment. It additionally features a touch panel for faster processes and a MyCV mode for personalized image configurations.
The global gynecological devices market is segmented on the endoscopy devices, endometrial ablation devices, and contraceptive devices. Based on the endoscopy devices, the market is sub-segmented into hysteroscope, resectoscope, colposcope, laparoscope, and endoscopic imaging systems. Based on the endometrial ablation devices, the market is sub-segmented into balloon ablation devices, hydrothermal ablation devices, radiofrequency ablation devices, and others. Furthermore, on the basis of contraceptive devices, the market is sub-segmented into temporary birth control, permanent birth control, diagnostic imaging systems, fluid management systems, and others. The laparoscope enterprise subcategory is expected to capture a significant portion of the market share within the endoscopy devices segment. The growth can be attributed to the numerous benefits of laparoscopic surgeries, including less blood loss, shorter hospital stays, and fewer intraoperative and postoperative issues.
Among the endoscopy devices, the hysteroscope sub-segment is expected to hold a considerable share of the global gynecological devices market. The segmental growth is attributed to the growing demand for improvement of skills and care quality. The improved training methods result in more skilled practitioners, ultimately improving the quality of treatment produced to hysteroscopic patients. For instance, in February 2021, VirtaMed launched hysteroscopy and gynecological laparoscopy mixed reality platform. Hysteroscopy training covers 16 instances for MyoSure tissue removal in addition to over 50 cases in diagnostics, polypectomy, myomectomy, tissue ablation, and advanced electrosurgical resection, all with competency-based objective feedback and complication management. The Gynecological Laparoscopy Simulator simulates surgical situations.
The global gynecological devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the growing awareness of birth control and contraception can boost regional product demand as a result of government seeks to reduce population growth. According to the World Health Organization, in September 2023, the demand for family planning among women has increased significantly over the last two decades, rising from 900 million in 2000 to approximately 1.1 billion in 2021. In addition, the adoption of contemporary contraceptive techniques has increased, rising from 663 million in 2000 to 851 million in 2020. According to projections, an additional 70 million women are projected to exceed the results by 2030, establishing a favorable trend in contraceptive prevalence rates, that have increased from 47.7% to 49.0% between 2000 and 2020.
Facts
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the optical technologies in a variety of applications across the region. The deployment of proceeds across endoscopy, pulse oximetry, laparoscopy, ophthalmology, and robotic surgery within the optical sector indicates the numerous applications of optical technologies. Its subsector targets distinctive clinical demands, ranging from minimally invasive surgical procedures to accurate diagnostic instruments, to satisfy a wide range of healthcare needs. According to the National Institute of Health (gov.) in December 2023, in imagining technology development, it is essential to evaluate the expenditure in research and development. By analyzing funding from the US National Institutes of Health (NIH), it emerged that radiological sectors receive $8.5 billion per year, accounting for 70% of device-based research, while optical sectors receive $3.6 billion per year, accounting for 30% of research, divided into microscopy, endoscopy, pulse oximetry, laparoscopy, ophthalmology, and robotic surgery. However, several technologies, such as MRI, nuclear medicine, and microscopy, have significant financing rates, with over 30% investment per technology valuation.
The major companies serving the gynecological devices market includes Elekta GmbH, FUJIFILM Corp., GE HealthCare Technologies Inc., Hologic, Inc., Johnson & Johnson Services, Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in in February 2023, Samsung Launched new AI-Enabled OB/GYN Ultrasound System. The use of the Advanced MV-FlowTM feature and a large organic light-emitting diode (OLED) display that allows improved characterization of varied ultrasound pictures, delivers 2D and 3D imaging of microcirculatory and sluggish blood.